共 39 条
- [1] Khaliq Y(2003)Fluoroquinolone-associated tendinopathy: a critical review of the literature Clin Infect Dis. 36 1404-1410
- [2] Zhanel GG(2009)Algorithms for assessing the probability of an adverse drug reaction Respiratory Medicine CME 2 2 63-67
- [3] Doherty M(1983)Norfloxacin-induced rheumatic disease [letter] N Z Med J. 96 590-1866
- [4] Bailey RR(2008)FDA adds “black box” warning label to fluoroquinolone antibiotics BMJ. 337 a816-36
- [5] Kirk JA(2012)Levofloxacin-induced tendinopathy of the hip Ann. Pharmacother. 46 e13-520
- [6] Peddie BA(2007)Safety concerns with fluoroquinolones Ann Pharmacother. 41 1859-277
- [7] Tanne JH(2005)Fluoroquinolones cause changes in extracellular matrix, signaling proteins, metalloproteinases and caspase-3 in cultured human tendon cells Toxicology. 212 24-471
- [8] Ganske CM(1996)Fluoroquinolone induced tendinopathy: report of 6 cases J Rheumatol. 23 516-620
- [9] Horning KK(2000)The effect of ciprofloxacin on tendon, paratendon, and capsular fibroblast metabolism Am J Sports Med. 28 364-625
- [10] Mehlhorn AJ(2002)Clinical toxicological aspects of fluoroquinolones Toxicol. Lett. 127 269-1231